Dimosthenis Mantopoulos is an Ophthalmology physician affiliated with Dartmouth–Hitchcock Medical Center. OpenAlex indexes 46 publications with 658 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 Plum St Ste 600
New Brunswick, NJ 089012065
Telephone
732-220-1600Provider last certified this registry record 22 Jun 2023.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202510 payments
- ANI Pharmaceuticals, Inc.Program year20254 payments
- Astellas Pharma US IncProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
94.6%Complement Inhibitor45.3%Avacincaptad pegol100%Part B, office-administered≥15 patientsAntineovascularisation agents44.8%Faricimab-svoa100%Part B, office-administered≥20 patients+ 6 more classes in this area
Cancer & immunology
4.6%Vascular Endothelial Growth Factor Inhibitor4.6%Aflibercept100%Part B, office-administered≥46 patientsMusculoskeletal
0.8%Cyclooxygenase Inhibitor0.8%Ketorolac Tromethamine100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer
2025 - Vitreoretinal Lymphoma Masquerading as Central Serous Chorioretinopathy
Ophthalmic surgery, lasers & imaging retina
2024 - Unexplained Vision Loss Associated With Intraocular Silicone Oil Tamponade in Rhegmatogenous Retinal Detachment Repair
Journal of VitreoRetinal Diseases
2023 - The Next-Generation Diagnostic and Therapeutic Algorithms for Diabetic Macular Edema Using Artificial Intelligence
Ophthalmic surgery, lasers & imaging retina
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Tanush Gupta, MD
Dartmouth–Hitchcock Medical Center
Jack Cronenwett, MD
Dartmouth–Hitchcock Medical Center
David Malenka, MD
Dartmouth–Hitchcock Medical Center
Robert Santulli, MD
Dartmouth–Hitchcock Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”